⌘K

Home/Filings/4/0000950170-25-029199

4//SEC Filing

AHMED NADIM 4

Accession 0000950170-25-029199

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 5:00 PM ET

Size

4.9 KB

Accession

0000950170-25-029199

Insider Transaction Report

Form 4

Period: 2025-02-25

Cullinan Therapeutics, Inc.CGEM

DirectorPresident and CEO

Transactions

Sale
Common Stock
2025-02-25$8.53/sh−12,529$106,872→ 430,621 total

Footnotes (1)

[F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cullinan Therapeutics, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001731193

Filing Metadata

Form type: 4
Filed: Feb 26, 7:00 PM ET
Accepted: Feb 27, 5:00 PM ET
Size: 4.9 KB

View on SEC.gov